–Former Cisco Executive brings more than 20 years of finance, field operations and human resources experience to AllscriptsCHICAGO, July 20, 2009 /PRNewswire-FirstCall via COMTEX/ — Allscripts (Nasdaq: MDRX) announced today that Diane Adams has joined the Company as Executive Vice President, Human Resources. Ms. Adams brings to the position more than 20 years of finance, field operations and human resources experience in the high tech industry, most recently as Vice President of Human Resources for Worldwide Sales and International Theaters at Cisco, a worldwide leader of networking for the Internet and a key Allscripts partner.
Ms. Adams joined Cisco in 1995 and was instrumental in shaping the HR vision, culture, and talent and executive development strategies that enabled Cisco to meet rapidly-changing business and market requirements. Over the past five years, Ms. Adams and her team at Cisco hired more than 25,000 individuals.
“Diane has a passion and talent for developing leaders, and solid experience in helping to shape the culture and workforce of Cisco, one of the IT industry’s great companies,” said Glen Tullman, Chief Executive Officer of Allscripts. “Her skill set will help Allscripts maintain and build upon its reputation as a top national employer during this time of significant growth for the company.”
Prior to joining Cisco, Ms. Adams served in a number of leadership roles within Nortel and also founded and operated a successful consulting business focused on organization and leadership development.
“I am excited to be joining the senior leadership team of a company that I have partnered with and long admired,” said Ms. Adams. “As Allscripts continues to grow quickly in response to strong market demand for their solutions, I look forward to helping develop and retain its innovative employees as well as recruit top new talent.”
Ms. Adams serves, along with Mr. Tullman, on the International Board of Directors of the Juvenile Diabetes Research Foundation and has served for the past seven years on the JDRF Board of Directors for the Triangle/Eastern North Carolina chapter. She has held several key leadership positions including Major Donor Committee Chair, JDRF Gala Chair, and Chair of the Walk to Cure Diabetes. In July, 2008, she received an “Award of Excellence” from JDRF for her leadership with the Major Donor program. This year, she is the recipient of the “Ruthie Award,” the Chapter’s highest volunteer leadership award.
Ms. Adams received the “2003 Women in Leadership” award for making an impact in business and the community within the Research Triangle Park area. She currently serves on the North Carolina Board of Directors of “Communities in Schools,” the nation’s leading community-based organization helping kids succeed in school and prepare for life. She recently served on the UNC Board of Visitors.
Ms. Adams holds a bachelor’s degree in Business Administration from the University of North Carolina at Chapel Hill. She will work out of the Company’s growing Raleigh, North Carolina campus and report directly to Mr. Tullman.
Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and nearly 8,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company’s award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, medication services, hospital care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.
For more Allscripts news, follow us on Twitter at: http://twitter.com/AllscriptsMisys
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company’s software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC (“MHS”); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2007 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.